Menu
Search

Tag: EGFR mutations

Browse exclusive Tags!

Johnson & Johnson Seeks EU Approval for Lazertinib + Rybrevant combo as First-Line Treatment for Advanced Non-Small Cell Lung Cancer

0
Johnson & Johnson seeks EU approval for a new combo treatment for advanced non-small cell lung cancer, offering hope for improved patient outcomes in EGFR mutations.

J INTS BIO Initiates Phase 1/2 Clinical Study of Novel EGFR TKI ‘JIN-A02’ for NSCLC Patients, South Korea

0
Learn about JIN-A02, a novel EGFR TKI for treating NSCLC patients. This Phase 1/2 study evaluates safety, pharmacokinetics, and anti-tumor activity.

Popular

Johnson & Johnson Seeks EU Approval for Lazertinib + Rybrevant combo as First-Line Treatment for Advanced Non-Small Cell Lung Cancer

Health 0
Johnson & Johnson seeks EU approval for a new combo treatment for advanced non-small cell lung cancer, offering hope for improved patient outcomes in EGFR mutations.

Subscribe

spot_imgspot_img

About us

Welcome to The Reportify Media Limited, your trusted source for comprehensive and reliable news reports. We are dedicated to bringing you the latest updates and insightful analysis on global events, politics, business, technology, and more. Stay informed and engaged with our well-researched articles, in-depth features, and thought-provoking perspectives. Join our community of informed readers as we navigate the complex world of news together.

Company

The latest

Revolutionary Small Business Exchange Network Connects Sellers and Buyers

Business 0
Revolutionary SBEN connects small business sellers and buyers, transforming the way businesses are bought and sold in the U.S.

District 1 Commissioner Race Results Delayed by Recounts & Ballot Reviews, US

Politics 0
District 1 Commissioner Race in Orange County faces delays with recounts and ballot reviews. Find out who will come out on top in this close election.

Fed Minutes Hint at Potential Rate Cut in September amid Economic Uncertainty, US

General 0
Federal Reserve minutes suggest potential rate cut in September amid economic uncertainty. Find out more about the upcoming policy decisions.

Subscribe

© 2023 The Reportify Media Limited. All Rights Reserved.